Activating mutations in the BRAF gene have received widespread attention in the past decade; nearly half of all melanomas have been shown to harbour mutations in BRAF at codon 600, which results in the constitutive activation of the MAPK pathway.1 This evidence concerns the gene BRAF and melanoma.